Skip to content

Upper jaw expansion with mini-implants with or without tiny bone holes

Comparative Evaluation of Maxillary Skeletal Expansion using Mini-implant Assisted Rapid Palatal Expander with and without Micro osteoperforation in the Mid Palatal Suture region: A Randomized Clinical Trial. - MARPE AND MOP

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/01/017137
Enrollment
22
Registered
2019-01-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R930- Abnormal findings on diagnostic imaging of skull and head, not elsewhere classified

Interventions

Intervention1: Mini-implant Assisted Rapid Palatal Expander with Micro osteoperforation: MICRO OSTEOPERFORATION IN MID PALATAL SUTURE REGION 6 MM AWAY FROM INCISIVE PAPILLA REGION FOLLOWED BY EXPANDER

Sponsors

DR MADHURA JAYANT PEDNEKAR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Subjects in the age group of 18 to 40 years of either gender indicated for skeletal maxillary expansion. 2) Subjects with good oral hygiene. 3) Subjects with healthy periodontal tissues. 4) Subjects with no prior history of orthodontic treatment and/ or orthognathic surgery. 5) Subjects with no severe dentofacial anomalies or syndromic conditions. 6) Subject with no radiographic evidence of bone loss. 7) Subject with no systemic disease or conditions.

Exclusion criteria

Exclusion criteria: Subjects other than the age group of 18 to 40 years. 2) Subjects without good oral hygiene. 3) Subjects with compromised periodontal tissues. 4) Subjects with prior history of orthodontic treatment and/ or orthognathic surgery. 5) Subjects with severe dentofacial anomalies or syndromic conditions. 6) Subject with radiographic evidence of bone loss. 7) Subject with systemic disease or conditions. 8) Subject with long term use of medications e.g. Antibiotics, phenytoin, cyclosporine, anti-inflammatory drugs, systemic corticosteroids, bisphosphonates.

Design outcomes

Primary

MeasureTime frame
MAXILLARY SKELETAL EXPANSION WITH MINIMAL DENTAL SIDE EFFECTSTimepoint: TWO MONTHS

Secondary

MeasureTime frame
LEESER ROOT RESORPTION, LESSER BUCCAL TIPPING, LESSER CHANCES OF BUCCAL BONY FENESTRATION AND DEHISCENCE OF ANCHOR TEETHTimepoint: TWO MONTHS

Countries

India

Contacts

Public ContactMADHURA JAYANT PEDNEKAR

MGM DENTAL COLLEGE AND HOSPITAL

drvivekpatni@gmail.com9324087948

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026